Shares of Symbiotec Pharmalab Ltd, a pharma and biotech company, made a muted market debut, listing nearly 1 per cent lower on the BSE against its issue price of Rs 988, but later recovered to trade higher.
Lupin said on Thursday it has made an equity investment in Symbiotec Pharmalab, a company focused on steroids, for a majority stake, in a bid to tap the over 10 illion dollar steroids market and is growing at about eight er cent annually.
The 15 proposals were cleared following recommendations by Foreign Investment Promotion Board.
